Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. - Wikidata - awgldk - TriplyDB

Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.

Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.

http://www.wikidata.org/entity/Q46614702

about

Overview of the Acetylcholine Spasm Provocation Test Syncope caused by coronary artery spasm without chest pain leading to ventricular fibrillation.Coronary artery spasm: Current knowledge and residual uncertainties.Coronary spasm that caused non-ST elevation myocardial infarction appeared in cath lab due to vasovagal reaction Coronary artery spasm: review and update.Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.Current advances in the understanding of coronary vasospasm.Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test.Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study.Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm.Statins in variant angina.Disruption of coronary vasomotor function: the coronary spasm syndrome.Post-valvular surgery multi-vessel coronary artery spasm - A literature review.Pharmacotherapy of Vasospastic Angina.Verapamil and vasospastic angina: underuse in the elderly population.Masked inherited primary arrhythmia syndromes in sudden cardiac death patients accompanied by coronary vasospasm.Access site-related complications after transradial catheterization can be reduced with smaller sheath size and statins.Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm.Moderate vasomotor response to acetylcholine provocation test as an indicator of long-term prognosis.Coronary stenosis as a modifier of the effect of cold spells on the risk of sudden cardiac death: a case-crossover study in Finland

P2860

Q26801781-D2ABE9B9-6DB9-4A7C-81E3-340654A8CCFA Q33162876-BE8F7ACB-6F67-45CE-9ACC-D2021C1DD65A Q33773703-F065C1B1-E5ED-4CE3-9806-6B60709D668E Q33941337-DCA8F4D9-2597-4ED9-883E-6353E9F11D4F Q34201543-111276CA-EB30-4FED-BB03-160714F8074E Q34313090-0E717B9F-7D32-4C1B-A537-4B6F4CDC3E86 Q34389782-EFF73710-65B5-4DD5-8922-C97173402C83 Q34444630-E9769AB2-A475-4B27-8961-1B7E21466471 Q35008152-D6773AF5-E67D-4B1F-BE82-C3053CD6F448 Q36247712-20D5BBFF-7D8D-4825-89EE-1F4435B84F1B Q36601920-38A2C346-E1C7-4232-B5D4-396D4644B69E Q36956805-07DE21FC-E16A-4CE3-87D5-A70DDDA44B72 Q36983233-276C35F8-156A-4FA9-AACD-BCCE4CCA5659 Q37800143-5B35241A-2816-4860-8E91-BB1FC4D551A1 Q39374959-EC5C2A01-E6DC-4032-BF57-5AD6ED73F84C Q39849053-F139AF82-BDB8-445C-8DD8-0BEF634C15C7 Q41265426-7F4830D3-39DA-469E-9DD8-E1C7E6DC3A0A Q41607570-F92C1209-372C-4CB1-A1EA-3B1EBFF9B9A8 Q43447905-F6FF9610-69FC-4D73-8202-600D093B0436 Q46395475-14D1D462-21B4-498D-BB35-E471B8E1341D Q53152240-8313215E-D6FF-4564-8921-F3DD11B11D0E Q57104164-C9D797FC-C9BD-4A06-8FB0-2CB9A49689B9

P2860

Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.

http://www.wikidata.org/entity/Q46614702

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@en

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@nl

type

label

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@en

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@nl

prefLabel

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@en

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@nl

P1433

Q46614702-37333308-E708-49F2-AD1D-BDCECB7461FE

P1476

Q46614702-11E7D034-08A1-4B6A-A422-251899F55D2A

P2093

Q46614702-078D09D4-5DA1-403E-B388-B3C1D75B9E0A

Q46614702-10F59BEA-6F22-436B-ADD4-AD9CFB7FB485

Q46614702-21606228-6198-47A4-8901-733723D52E01

Q46614702-2473F4F2-B029-4619-8E9A-1247C44DF583

Q46614702-3AF01445-9418-4A67-9602-4FA91FD58B74

Q46614702-3D423B74-838B-48F9-85DD-714BBEBD411A

Q46614702-4855D5FC-FF95-4853-BD04-548C8EF6184E

Q46614702-51D509C9-8965-43EE-8772-45321510E8CC

Q46614702-5D44CF81-0CA2-4DE1-97AE-13B2A4B02E6C

Q46614702-65AA8ADA-1EC8-44CF-A5C2-9471E8A2B9A1

P304

Q46614702-77333843-6D49-4102-8794-39E8ED74C784

P31

Q46614702-F33D974B-AF8E-4178-9730-1558353F363C

P356

Q46614702-C3F1A8EC-66BA-40DA-9598-210B82BD6E74

P407

Q46614702-B60A3AB4-7C1C-49FE-B56C-8C371E0AC51D

P433

Q46614702-E4DCE896-4F21-4F6A-B853-7FEC4598225D

P478

Q46614702-3E9A7139-7AE8-41CC-A90E-4B28E45239B2

P577

Q46614702-33F3BAB0-4B47-4938-B7FB-C4D3E65448EB

P5875

Q46614702-92294232-8BA1-4106-9A5B-8BCD34EAE780

P698

Q46614702-3A9E3742-FBF5-4F3F-8ACB-A8B82FE890CC

P356

J.JACC.2007.12.049

P1433

Journal of the American College of Cardiology

P1476

Effects of a 3-hydroxy-3-methy ...... l of calcium-channel blockers.

@en

P2093

Eisaku Harada

http://www.w3.org/2001/XMLSchema#string

Hirofumi Yasue

http://www.w3.org/2001/XMLSchema#string

Hisao Ogawa

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nakagawa

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Kugiyama

http://www.w3.org/2001/XMLSchema#string

Masafumi Nakayama

http://www.w3.org/2001/XMLSchema#string

Masaki Harada

http://www.w3.org/2001/XMLSchema#string

Michihiro Yoshimura

http://www.w3.org/2001/XMLSchema#string

Minoru Horie

http://www.w3.org/2001/XMLSchema#string

SCAST (Statin and Coronary Artery Spasm Trial) Investigators

http://www.w3.org/2001/XMLSchema#string

P304

1742-1748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2007.12.049

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5399533

http://www.w3.org/2001/XMLSchema#string

P698

18452779

http://www.w3.org/2001/XMLSchema#string